Menopausal Hormone Therapy and Colorectal Cancer Risk Menopausal Hormone Therapy and Colorectal Cancer Risk
Might menopausal hormone therapy help protect against the development of colorectal cancer? This review examines the evidence.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 16, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
Can belly dance and mat Pilates be effective for range of motion, self-esteem, and depressive symptoms of breast cancer women? - Leite B, de Bem Fretta T, Boing L, Coutinho de Azevedo Guimar ães A.
This study aims to analyse the effect of an intervention with belly dance or mat Pilates on range of motion, self-esteem and depressive symptoms in women with breast cancer receiving hormone therapy. METHOD: A randomized clinical trial o... (Source: SafetyLit)
Source: SafetyLit - September 15, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
FDA Approves First Once-Weekly Growth Hormone for Children FDA Approves First Once-Weekly Growth Hormone for Children
' I am excited to be able to reduce the number of shots for some children requiring growth hormone therapy, ' said one pediatric endocrinologist, referring to weekly lonapegsomatropin.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - September 2, 2021 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Alert Source Type: news
Rates of Obesity, Weight Gain Up for Transmasculine Individuals
WEDNESDAY, Aug. 25, 2021 -- Transmasculine individuals have greater rates of obesity and increased weight gain before and during hormone therapy compared with transfeminine individuals, according to a study published online Aug. 16 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 25, 2021 Category: Pharmaceuticals Source Type: news
Safety and Efficacy of Compounded Bioidentical Hormone Therapy Safety and Efficacy of Compounded Bioidentical Hormone Therapy
A recent analysis published by the National Academies of Sciences, Engineering, and Medicine recommends against prescribing compounded hormone medications. Review their concerns in this paper.Menopause (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 23, 2021 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news
Five - Year Extended Hormone Therapy No Better in Breast Cancer
Findings compared with two years of extended adjuvant anastrozole in postmenopausal women with hormone - receptor - positive breast cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 29, 2021 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Pharmacy, Journal, Source Type: news
Five-Year Extended Hormone Therapy No Better in Breast Cancer
THURSDAY, July 29, 2021 -- Extending hormone therapy by five years does not provide benefit over a two-year extension among postmenopausal women with hormone receptor-positive breast cancer who had received five years of adjuvant endocrine therapy,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 29, 2021 Category: Pharmaceuticals Source Type: news
Could Menopausal Hormone Therapy Reduce Women's Odds for Dementia?
Title: Could Menopausal Hormone Therapy Reduce Women ' s Odds for Dementia?Category: Health NewsCreated: 7/20/2021 12:00:00 AMLast Editorial Review: 7/21/2021 12:00:00 AM (Source: MedicineNet Menopause General)
Source: MedicineNet Menopause General - July 21, 2021 Category: Primary Care Source Type: news
Could Menopausal Hormone Therapy Reduce Women's Odds for Dementia?
TUESDAY, July 20, 2021 -- Women on hormone replacement therapy (HRT) for menopause go on to have a 58% lower risk of Alzheimer ' s disease and other neurodegenerative conditions, a new study finds.
Although the study wasn ' t designed to prove cause and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 20, 2021 Category: General Medicine Source Type: news
Tool helps predict who will respond best to targeted prostate cancer therapy
A new prognostic tool developed by researchers from theUCLA Jonsson Comprehensive Cancer Center and five other institutionshelps predict which men with advanced metastatic prostate cancer will respond favorably to a novel targeted therapy.The tool,described in a study published today in Lancet Oncology, analyzesa wide spectrum of imaging and clinical data and is intended to assist physicians considering treating patients with Lutetium-177 prostate-specific membrane antigen, or LuPSMA.LuPSMA, which binds to PSMA proteins and delivers targeted radiation to prostate cancer tissue, offers a new option to men with PSMA-positive...
Source: UCLA Newsroom: Health Sciences - July 12, 2021 Category: Universities & Medical Training Source Type: news
Tool helps predicts who will respond best to targeted prostate cancer therapy
A new prognostic tool developed by researchers from theUCLA Jonsson Comprehensive Cancer Center and five other institutionshelps predict which men with advanced metastatic prostate cancer will respond favorably to a novel targeted therapy.The tool,described in a study published today in Lancet Oncology, analyzesa wide spectrum of imaging and clinical data and is intended to assist physicians considering treating patients with Lutetium-177 prostate-specific membrane antigen, or LuPSMA.LuPSMA, which binds to PSMA proteins and delivers targeted radiation to prostate cancer tissue, offers a new option to men with PSMA-positive...
Source: UCLA Newsroom: Health Sciences - July 9, 2021 Category: Universities & Medical Training Source Type: news
' Treat Youth With Gender Dysphoria as Individuals'' Treat Youth With Gender Dysphoria as Individuals '
Last week the Tavistock appealed a High Court ruling that adolescents with gender dysphoria were unlikely to fully understand the consequences of hormone therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 27, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
Consumer Health: Hormone therapy for people who are transgender
Transgender is an umbrella term used to capture the spectrum of gender identity and gender-expression diversity. Gender identity is the internal sense of being male, female, neither or both. Gender expression involves the expression of a person's gender identity through social roles, appearance and behaviors. Most children categorize their own gender by 3. However, because [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 24, 2021 Category: Databases & Libraries Source Type: news
Hormone Pellet Safety Data'Not Very Reassuring at All' for Women Hormone Pellet Safety Data'Not Very Reassuring at All' for Women
Women who receive pellet hormonal therapy may be significantly more likely to have side effects compared with women who receive FDA-approved hormonal treatments.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - June 18, 2021 Category: Primary Care Tags: Ob/Gyn & Women ' s Health News Source Type: news
AHA News: At 17, He Received a New Heart. By 23, He Began Transitioning.
FRIDAY, June 18, 2021 (American Heart Association News) -- For most transgender people, starting hormone therapy requires a therapist ' s approval. As the recipient of a new heart, Maddox Jones also needed his transplant team ' s OK. " It was a long and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 18, 2021 Category: General Medicine Source Type: news
